COMPLETED

Erector Spinae Plane Block for Uncomplicated Renal Colic

Conditions

Renal Colic Kidney Stone erector spinae plane block Emergency Department ropivacaine

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.

Official Title

Erector Spinae Plane Block for Uncomplicated Renal Colic

Quick Facts

Study Start:2023-02-08

Study Completion:2024-02-02

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT05625802

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Imaging confirmation of urolithiasis on the index encounter or prior encounter within 7 days * Patient received one dose of parenteral pain medication in the emergency department (ED)	* Pregnancy or breastfeeding * Prisoner or incarcerated individual * Therapeutic anticoagulation or coagulopathy. * Active treatment for urinary tract infection (either acute infection or chronic therapy) * Prior spinal surgery in the thoracic region * Allergy to local anesthetic or prior local anesthetic * Soft tissue infection overlying the injection site * Positive for coronavirus * Inability to communicate verbally or read/write in English * Currently taking strong CYP1A2 inhibitor (fluvoxamine, amiodarone, fluoroquinolones, etc.) * Glucose-6-phosphate dehydrogenase deficiency (G6PD)

Inclusion Criteria

Exclusion Criteria

* Imaging confirmation of urolithiasis on the index encounter or prior encounter within 7 days
* Patient received one dose of parenteral pain medication in the emergency department (ED)

* Pregnancy or breastfeeding
* Prisoner or incarcerated individual
* Therapeutic anticoagulation or coagulopathy.
* Active treatment for urinary tract infection (either acute infection or chronic therapy)
* Prior spinal surgery in the thoracic region
* Allergy to local anesthetic or prior local anesthetic
* Soft tissue infection overlying the injection site
* Positive for coronavirus
* Inability to communicate verbally or read/write in English
* Currently taking strong CYP1A2 inhibitor (fluvoxamine, amiodarone, fluoroquinolones, etc.)
* Glucose-6-phosphate dehydrogenase deficiency (G6PD)

Contacts and Locations

Principal Investigator

Chris Fung

STUDY_CHAIR

University of Michigan

Study Locations (Sites)

The University of Michigan

Ann Arbor, Michigan, 48109

United States

Collaborators and Investigators

Sponsor: University of Michigan

Chris Fung, STUDY_CHAIR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-08

Study Completion Date2024-02-02

Study Record Updates

Study Start Date2023-02-08

Study Completion Date2024-02-02

Terms related to this study

Keywords Provided by Researchers

erector spinae plane block
Emergency Department
ropivacaine

Additional Relevant MeSH Terms

Renal Colic
Kidney Stone